Photo from Khaled Musallam/LinkedIn
May 27, 2024, 14:32
Khaled Musallam: Abstracts presented during the WIN Symposium 2024 are now published in the Journal of Immunotherapy and Precision Oncology
Khaled Musallam, Founding Director of Center for Research on Rare Blood Disorders (CR-RBD) at Burjeel Holdings, shared on their LinkedIn:
”Happy to share that abstracts presented during the WIN Symposium 2024 are now published in the Journal of Immunotherapy and Precision Oncology.”
Read further.
Source: Khaled Musallam/LinkedIn
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Dec 21, 2024, 22:40
Dec 21, 2024, 22:37
Dec 21, 2024, 22:26
Dec 21, 2024, 19:39
Dec 21, 2024, 19:21
Dec 21, 2024, 19:19